GHIT Fund invests Y1.64bn in malaria and NTD drug development
Shionogi, Nagasaki University, the National Institute of Infectious Diseases and MMV are working on a malaria chemoprevention drug. Credit: namtipStudio/Shuttersttock.com. The Global Health Innovative Technology